1.Du J, Jin T, Cao Y, Chen J, Guo Y, Sun M, Li J, Zhang X, Wang G, Wang J: Association between genetic polymorphisms of MMP8 and the risk of steroid-induced osteonecrosis of the femoral head in the population of northern China. Medicine 2016, 95(37):e4794.
2.Wang A, Ren M, Wang J: The pathogenesis of steroid-induced osteonecrosis of the femoral head: A systematic review of the literature. Gene 2018.
3.Nakatochi M, Ichihara S, Yamamoto K, Ohnaka K, Kato Y, Yokota S, Hirashiki A, Naruse K, Asano H, Izawa H et al: Epigenome-wide association study suggests that SNPs in the promoter region of RETN influence plasma resistin level via effects on DNA methylation at neighbouring sites. Diabetologia 2015, 58(12):2781–2790.
4.Aimaiti A, Wufuer M, Wang YH, Saiyiti M, Cui L, Yusufu A: Can bisphenol A diglycidyl ether (BADGE) administration prevent steroid-induced femoral head osteonecrosis in the early stage? Medical hypotheses 2011, 77(2):282–285.
5.Zhang Y, Yin J, Ding H, Zhang C, Gao YS: Vitamin K2 Ameliorates Damage of Blood Vessels by Glucocorticoid: a Potential Mechanism for Its Protective Effects in Glucocorticoid-induced Osteonecrosis of the Femoral Head in a Rat Model. International journal of biological sciences 2016, 12(7):776–785.
6.Du J, Liu W, Jin T, Zhao Z, Bai R, Xue H, Chen J, Sun M, Zhang X, Wang G et al: A single-nucleotide polymorphism in MMP9 is associated with decreased risk of steroid-induced osteonecrosis of the femoral head. Oncotarget 2016, 7(42):68434–68441.
7.Qi Y, Wang J, Sun M, Ma C, Jin T, Liu Y, Cao Y, Wang J: MMP–14 single-nucleotide polymorphisms are related to steroid-induced osteonecrosis of the femoral head in the population of northern China. Molecular genetics & genomic medicine 2018.
8.Zhang Y, Kong X, Wang R, Li S, Niu Y, Zhu L, Chen W, Lin N: Genetic association of the P-glycoprotein gene ABCB1 polymorphisms with the risk for steroid-induced osteonecrosis of the femoral head in Chinese population. Molecular biology reports 2014, 41(5):3135–3146.
9.Ma W, Xin K, Chen K, Tang H, Chen H, Zhi L, Liu H: Relationship of common variants in VEGFA gene with osteonecrosis of the femoral head: A Han Chinese population based association study. Scientific reports 2018, 8(1):16221.
10.Kim HJ, Lee YS, Won EH, Chang IH, Kim TH, Park ES, Kim MK, Kim W, Myung SC: Expression of resistin in the prostate and its stimulatory effect on prostate cancer cell proliferation. BJU international 2011, 108(2 Pt 2):E77–83.
11.Younis S, Blumenberg M, Javed Q: Resistin gene polymorphisms are associated with acne and serum lipid levels, providing a potential nexus between lipid metabolism and inflammation. Archives of dermatological research 2016, 308(4):229–237.
12.Hornik B, Dulawa J, Szewieczek J, Durmala J: Physical activity increases the resistin concentration in hemodialyzed patients without metabolic syndrome. Diabetes, metabolic syndrome and obesity: targets and therapy 2019, 12:43–57.
13.Johnson C, Drummer Ct, Virtue A, Gao T, Wu S, Hernandez M, Singh L, Wang H, Yang XF: Increased Expression of Resistin in MicroRNA–155-Deficient White Adipose Tissues May Be a Possible Driver of Metabolically Healthy Obesity Transition to Classical Obesity. Frontiers in physiology 2018, 9:1297.
14.Ohmori R, Momiyama Y, Kato R, Taniguchi H, Ogura M, Ayaori M, Nakamura H, Ohsuzu F: Associations between serum resistin levels and insulin resistance, inflammation, and coronary artery disease. Journal of the American College of Cardiology 2005, 46(2):379–380.
15.Ikeda Y, Tsuchiya H, Hama S, Kajimoto K, Kogure K: Resistin affects lipid metabolism during adipocyte maturation of 3T3-L1 cells. The FEBS journal 2013, 280(22):5884–5895.
16.Gabriel S, Ziaugra L, Tabbaa D: SNP genotyping using the Sequenom MassARRAY iPLEX platform. Current protocols in human genetics 2009, Chapter 2:Unit 2.12.
17.Lehrke M, Reilly MP, Millington SC, Iqbal N, Rader DJ, Lazar MA: An inflammatory cascade leading to hyperresistinemia in humans. PLoS medicine 2004, 1(2):e45.
18.Reilly MP, Lehrke M, Wolfe ML, Rohatgi A, Lazar MA, Rader DJ: Resistin is an inflammatory marker of atherosclerosis in humans. Circulation 2005, 111(7):932–939.
19.McTernan CL, McTernan PG, Harte AL, Levick PL, Barnett AH, Kumar S: Resistin, central obesity, and type 2 diabetes. Lancet (London, England) 2002, 359(9300):46–47.
20.Degawa-Yamauchi M, Bovenkerk JE, Juliar BE, Watson W, Kerr K, Jones R, Zhu Q, Considine RV: Serum resistin (FIZZ3) protein is increased in obese humans. The Journal of clinical endocrinology and metabolism 2003, 88(11):5452–5455.
21.Verma S, Li SH, Wang CH, Fedak PW, Li RK, Weisel RD, Mickle DA: Resistin promotes endothelial cell activation: further evidence of adipokine-endothelial interaction. Circulation 2003, 108(6):736–740.
22.Onuma H, Tabara Y, Kawamura R, Tanaka T, Ohashi J, Nishida W, Takata Y, Ochi M, Yamada K, Kawamoto R et al: A at single nucleotide polymorphism–358 is required for G at –420 to confer the highest plasma resistin in the general Japanese population. PloS one 2010, 5(3):e9718.
23.Asano H, Izawa H, Nagata K, Nakatochi M, Kobayashi M, Hirashiki A, Shintani S, Nishizawa T, Tanimura D, Naruse K et al: Plasma resistin concentration determined by common variants in the resistin gene and associated with metabolic traits in an aged Japanese population. Diabetologia 2010, 53(2):234–246.
24.Apalasamy YD, Rampal S, Salim A, Moy FM, Su TT, Majid HA, Bulgiba A, Mohamed Z: Polymorphisms of the resistin gene and their association with obesity and resistin levels in Malaysian Malays. Biochemical genetics 2015, 53(4–6):120–131.
25.Hivert MF, Manning AK, McAteer JB, Dupuis J, Fox CS, Cupples LA, Meigs JB, Florez JC: Association of variants in RETN with plasma resistin levels and diabetes-related traits in the Framingham Offspring Study. Diabetes 2009, 58(3):750–756.
26.Fu Y, Yu Y, Wu Y, You Y, Zhang Y, Kou C: Association between Two Resistin Gene Polymorphisms and Metabolic Syndrome in Jilin, Northeast China: A Case-Control Study. Disease markers 2017, 2017:1638769.
27.Osawa H, Tabara Y, Ohashi J, Kawamura R, Onuma H, Makino H: Is rs34861192 or rs1862513 a more promising variant for determining plasma resistin in an aged Japanese population? Diabetologia 2010, 53(4):795–797.